Program
E6742
A development code.
Its studies are mostly in Lupus Erythematosus, Systemic, led by Eisai.
Furthest: phase 2, since Mar 4, 20224 company-led studies, 1 open or runningNext primary completion: Aug 5, 2028 (phase 2)
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Eisai | 41 open or running | phase 2since Mar 4, 2022 | Mar 14, 2017 | Aug 5, 2028phase 2 · NCT07515014 |
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Mar 14, 2017First study: phase 1 study in Healthy ParticipantsFirst studyNCT03082235 · 72 enrolled · United States
- Dec 21, 2020Phase 1 study in Healthy VolunteersNCT04683185 · 24 enrolled · Japan
- Mar 4, 2022Phase 2 study in Lupus Erythematosus, SystemicNCT05278663 · 26 enrolled · Japan
- Mar 11, 2026Phase 2 study in Lupus Erythematosus, SystemicNCT07515014 · 256 planned · China, Japan, South Korea and more
Ahead
- Aug 5, 2028Primary completion: phase 2 study in Lupus Erythematosus, SystemicNCT07515014
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 4 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07515014Lupus Erythematosus, Systemic · China, Japan, South Korea and more | 2 | Recruiting | Aug 5, 2028 | 256 |
| NCT05278663Lupus Erythematosus, Systemic · Japan | 2 | Completed | Sep 4, 2023 | 26 |
| NCT04683185Healthy Volunteers · Japan | 1 | Completed | Jun 21, 2021 | 24 |
| NCT03082235Healthy Participants · United States | 1 | Completed | Oct 11, 2017 | 72 |
How it is read
Names in the registry
- “E6742”, 4 entries
Codes read as this program: E6742.
Conditions, from the studies’ own filings
- Lupus Erythematosus, Systemic, 2 studies
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.